Literature DB >> 22458864

Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress.

Ritu Chhillar1, Dinesh Dhingra.   

Abstract

This study was designed to evaluate antidepressant-like activity of gallic acid in Swiss young male albino mice subjected to unpredictable chronic mild stress and to explore the possible underlying mechanisms for this activity. Gallic acid (5, 10, 20 mg/kg, i.p.) and fluoxetine (10 mg/kg, i.p.) per se were administered daily to unstressed mice and other groups of mice subjected to unpredictable mild stress, 30 min after the injection for 21 successive days. The antidepressant-like activity was evaluated using forced swim test (FST) and sucrose preference test. Stress significantly increased immobility period of mice in FST. Gallic acid (10 and 20 mg/kg, i.p.) and fluoxetine significantly decreased immobility period of unstressed and stressed mice in FST and prevented the stress-induced decrease in sucrose preference, indicating significant antidepressant-like activity. There was no significant effect on locomotor activity of the mice by the drugs. Gallic acid (10 and 20 mg/kg, i.p.) significantly decreased Monoamine oxidase-A (MAO-A) activity, malondialdehyde levels, and catalase activity in unstressed mice; and significantly prevented the stress-induced decrease in reduced glutathione and catalase activity; and also significantly prevented stress-induced increase in MAO-A activity, malondialdehyde levels, plasma nitrite, and corticosterone levels. Thus, gallic acid showed antidepressant-like activity in unstressed and stressed mice probably due to its antioxidant activity and through inhibition of MAO-A activity and decrease in plasma nitrite levels. In addition, gallic acid also showed antidepressant-like activity in stressed mice probably through decrease in plasma corticosterone levels.
© 2012 The Authors Fundamental and Clinical Pharmacology © 2012 Société Française de Pharmacologie et de Thérapeutique. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458864     DOI: 10.1111/j.1472-8206.2012.01040.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  20 in total

1.  Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.

Authors:  G F Brum; H Z Rosa; D R Rossato; J L O Rosa; V G Metz; L H Milanesi; M E Burger
Journal:  Neurotox Res       Date:  2020-05-26       Impact factor: 3.911

2.  Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations.

Authors:  Monu Yadav; Deepak Kumar Jindal; Mamta Sachdeva Dhingra; Anil Kumar; Milind Parle; Sameer Dhingra
Journal:  Inflammopharmacology       Date:  2017-06-02       Impact factor: 4.473

3.  Antidepressant activity of phytochemicals of Mangifera indica seeds assisted by integrated computational analysis.

Authors:  Uzma Saleem; Shafa Iman; Bashir Ahmad; Muhammad Ajmal Shah; Shabana Bibi; Mohammed Alqarni; Muhammad Saad Khan; Ghulam Mujtaba Shah; Haroon Khan; Reem Hasaballah Alhasani; Norah A Althobaiti; Aishah E Albalawi
Journal:  Metab Brain Dis       Date:  2022-03-28       Impact factor: 3.584

4.  Evaluation of the therapeutic effect of mesoporous silica nanoparticles loaded with Gallic acid on reserpine-induced depression in Wistar rats.

Authors:  Heba M Fahmy; Eman R Mohamed; Aida A Hussein; Yasser A Khadrawy; Nawal A Ahmed
Journal:  BMC Pharmacol Toxicol       Date:  2022-06-15       Impact factor: 2.605

5.  Gallic acid activates hippocampal BDNF-Akt-mTOR signaling in chronic mild stress.

Authors:  Ji-Xiao Zhu; Jia-Ling Shan; Wei-Qiong Hu; Jin-Xiang Zeng; Ji-Cheng Shu
Journal:  Metab Brain Dis       Date:  2018-10-03       Impact factor: 3.584

6.  Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.

Authors:  Takashi Mori; Naoki Koyama; Tomotaka Yokoo; Tatsuya Segawa; Masahiro Maeda; Darrell Sawmiller; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

7.  The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.

Authors:  Mariana Machado Pereira; Helen de Morais; Eldevan Dos Santos Silva; Claudia Rita Corso; Eliana Rezende Adami; Rose Maria Carlos; Alexandra Acco; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2018-06-23       Impact factor: 3.584

Review 8.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

9.  Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice.

Authors:  Monu Yadav; Milind Parle; Nidhi Sharma; Sameer Dhingra; Neha Raina; Deepak Kumar Jindal
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Post-Stroke Depression Modulation and in Vivo Antioxidant Activity of Gallic Acid and Its Synthetic Derivatives in a Murine Model System.

Authors:  Seyed Fazel Nabavi; Solomon Habtemariam; Arianna Di Lorenzo; Antoni Sureda; Sedigheh Khanjani; Seyed Mohammad Nabavi; Maria Daglia
Journal:  Nutrients       Date:  2016-04-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.